表紙:多嚢胞性卵巣症候群治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
市場調査レポート
商品コード
1028791

多嚢胞性卵巣症候群治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)

Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
多嚢胞性卵巣症候群治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の多嚢胞性卵巣症候群治療薬の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し、薬剤の種類別および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 多嚢胞性卵巣症候群治療薬市場の特徴

第3章 多嚢胞性卵巣症候群治療薬市場の傾向と戦略

第4章 多嚢胞性卵巣症候群治療薬市場に対する新型コロナウイルス感染症 (COVID-19) の影響

第5章 多嚢胞性卵巣症候群治療薬市場:市場規模・成長率

  • 市場規模 (単位:10億米ドル、2015年~2020年)
    • 市場促進要因
    • 市場抑制要因
  • 市場規模 (単位:10億米ドル、2020年~2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第6章 多嚢胞性卵巣症候群治療薬市場:分野別の分析

  • 薬剤の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 経口避妊薬
  • オルニチンデカルボキシラーゼ阻害剤
  • インスリン抵抗性改善薬
  • 抗うつ剤
  • 利尿薬
  • アロマターゼ阻害剤
  • 手術の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 卵巣楔状切除術
  • 腹腔鏡下卵巣穿孔
  • エンドユーザー別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 病院・クリニック
  • 外来手術センター
  • 診断センター
  • 婦人科センター
  • 女性向け医療センター

第7章 多嚢胞性卵巣症候群治療薬市場:地域別・国別分析

  • 地域別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 国別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第8章 アジア太平洋の多嚢胞性卵巣症候群治療薬市場

  • 市場概要
  • 地域情報
  • 薬剤の種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧の多嚢胞性卵巣症候群治療薬市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 東欧の多嚢胞性卵巣症候群治療薬市場

第20章 ロシア市場

第21章 北米の多嚢胞性卵巣症候群治療薬市場

第22章 米国市場

第23章 南米の多嚢胞性卵巣症候群治療薬市場

第24章 ブラジル市場

第25章 中東の多嚢胞性卵巣症候群治療薬市場

第26章 アフリカの多嚢胞性卵巣症候群治療薬市場

第27章 多嚢胞性卵巣症候群治療薬市場:競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Bristol-Myer Squibb Company
    • Bayer AG
    • Pfizer, Inc.
    • Merck KGaA
    • Sanofi

第28章 多嚢胞性卵巣症候群治療薬のパイプライン製品の分析

第29章 多嚢胞性卵巣症候群治療薬市場における主要な企業合併・買収 (M&A)

第30章 多嚢胞性卵巣症候群治療薬市場:将来展望と潜在力の分析

第31章 付録

目次
Product Code: h815

“Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global polycystic ovarian syndrome treatment market.

This report focuses on polycystic ovarian syndrome treatment market which is experiencing strong growth. The report gives a guide to the polycystic ovarian syndrome treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the polycystic ovarian syndrome treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Polycystic Ovarian Syndrome Treatment market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider polycystic ovarian syndrome treatment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The polycystic ovarian syndrome treatment market section of the report gives context. It compares the polycystic ovarian syndrome treatment market with other segments of the polycystic ovarian syndrome treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, polycystic ovarian syndrome treatment indicators comparison.

Scope

Markets Covered:

1) By Drug Type: Oral Contraceptives; Ornithine Decarboxylase Inhibitors; Insulin-Sensitizing Agents; Anti-Depressants; Diuretics; Aromatase Inhibitors

2) By Surgery Type: Ovarian Wedge Resection; Laparoscopic Ovarian Drilling

3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Diagnostic Centers; Gynecology Centers; Feminist Health Centers

Companies Mentioned: Bristol-Myer Squibb Company; Bayer AG; Pfizer, Inc.; Merck KGaA; Sanofi

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Polycystic Ovarian Syndrome Treatment Market Characteristics

3. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies

4. Impact Of COVID-19 On Polycystic Ovarian Syndrome Treatment

5. Polycystic Ovarian Syndrome Treatment Market Size And Growth

  • 5.1. Global Polycystic Ovarian Syndrome Treatment Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Polycystic Ovarian Syndrome Treatment Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Polycystic Ovarian Syndrome Treatment Market Segmentation

  • 6.1. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral Contraceptives
  • Ornithine Decarboxylase Inhibitors
  • Insulin-Sensitizing Agents
  • Anti-Depressants
  • Diuretics
  • Aromatase Inhibitors
  • 6.2. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling
  • 6.3. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Gynecology Centers
  • Feminist Health Centers

7. Polycystic Ovarian Syndrome Treatment Market Regional And Country Analysis

  • 7.1. Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market

  • 8.1. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Polycystic Ovarian Syndrome Treatment Market

  • 9.1. China Polycystic Ovarian Syndrome Treatment Market Overview
  • 9.2. China Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Polycystic Ovarian Syndrome Treatment Market

  • 10.1. India Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Polycystic Ovarian Syndrome Treatment Market

  • 11.1. Japan Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Polycystic Ovarian Syndrome Treatment Market

  • 12.1. Australia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Polycystic Ovarian Syndrome Treatment Market

  • 13.1. Indonesia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Polycystic Ovarian Syndrome Treatment Market

  • 14.1. South Korea Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Polycystic Ovarian Syndrome Treatment Market

  • 15.1. Western Europe Polycystic Ovarian Syndrome Treatment Market Overview
  • 15.2. Western Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Polycystic Ovarian Syndrome Treatment Market

  • 16.1. UK Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Polycystic Ovarian Syndrome Treatment Market

  • 17.1. Germany Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Polycystic Ovarian Syndrome Treatment Market

  • 18.3. France Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Polycystic Ovarian Syndrome Treatment Market

  • 19.1. Eastern Europe Polycystic Ovarian Syndrome Treatment Market Overview
  • 19.2. Eastern Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Polycystic Ovarian Syndrome Treatment Market

  • 20.1. Russia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Polycystic Ovarian Syndrome Treatment Market

  • 21.1. North America Polycystic Ovarian Syndrome Treatment Market Overview
  • 21.2. North America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Polycystic Ovarian Syndrome Treatment Market

  • 22.1. USA Polycystic Ovarian Syndrome Treatment Market Overview
  • 22.2. USA Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Polycystic Ovarian Syndrome Treatment Market

  • 23.1. South America Polycystic Ovarian Syndrome Treatment Market Overview
  • 23.2. South America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Polycystic Ovarian Syndrome Treatment Market

  • 24.1. Brazil Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Polycystic Ovarian Syndrome Treatment Market

  • 25.1. Middle East Polycystic Ovarian Syndrome Treatment Market Overview
  • 25.2. Middle East Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Polycystic Ovarian Syndrome Treatment Market

  • 26.1. Africa Polycystic Ovarian Syndrome Treatment Market Overview
  • 26.2. Africa Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape
  • 27.2. Polycystic Ovarian Syndrome Treatment Market Company Profiles
    • 27.2.1. Bristol-Myer Squibb Company
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Bayer AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Pfizer, Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Merck KGaA
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sanofi
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Polycystic Ovarian Syndrome Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Polycystic Ovarian Syndrome Treatment Market

30. Polycystic Ovarian Syndrome Treatment Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer